Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type B vs type A and placebo for sialorrhoea in neurodegenerative diseases
2005-000901-77Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type b in hypersalivation (3 arms), sponsored by Policlinico Gemelli. Primary endpoints: Efficacy of botulinum toxin type B vs placebo and botulinum toxin type A and Safety of botulinum toxin type B in salivary glands. Started Nov 2007; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
hypersalivation
Beyond the preview
Go deeper on 2005-000901-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000901-77.